Clinical outcomes of different preoperative treatment approaches in locally advanced rectal cancer: real-world experience

Information from the abstract

Abstract Background: To date, standard treatment for locally advanced rectal cancer (LARC) is total neoadjuvant therapy (TNT). Neoadjuvant chemoradiotherapy (nCRT) followed by surgery is the other option. This study aimed to compare the outcomes of various preoperative treatment strategies in real world setting. Methods: A retrospective and prospective analysis of stage II-III LARC patients receiving nCRT between January 2018 and October 2023 was conducted. Preoperative strategies were categorized into 3 groups: conventional nCRT, TNT, and nCRT with perioperative chemotherapy(nCRT-POC). We analyzed pathological complete response (pCR), event-free survival (EFS), and overall survival (OS). Results: Among 339 patients who completed preoperative treatment, 46%, 45%, and 9% of patients were treated with conventional nCRT, TNT, and nCRT-POC, respectively. During the treatment, 24 patients experienced tumor progressions, while 27 achieved a clinical complete response and underwent the watch-and-wait approach. Pathological data were available for 274 patients. The pCR rates were 11%, 24%, and 31% for the conventional nCRT, TNT, and nCRT-POC groups, respectively. Factors associated with pCR included poorly differentiated histology (OR: 7.1; P = 0.018), and TNT or nCRT-POC strategy (OR: 2.37; P = 0.03). Patients achieving pCR had significantly improved 3-year EFS (HR: 0.17; P

Why this record is monitored

This record has an Impact Signal of 74/100 based on recency, source, collaboration, and bibliographic signals. It prioritizes monitoring and is not a judgment of research quality.

Related topics: Colorectal Cancer Surgical Treatments · Colorectal and Anal Carcinomas · MRI in cancer diagnosis